B precursor type acute leukaemia and Nosebleed

---

Gender of people who have B Precursor Type Acute Leukaemia and experienced Nosebleed *:

• female: 7.69 %
• male: 92.31 %

Age of people who have B Precursor Type Acute Leukaemia and experienced Nosebleed *:

• 0-1: 0.0 %
• 2-9: 8.33 %
• 10-19: 58.33 %
• 20-29: 8.33 %
• 30-39: 0.0 %
• 40-49: 8.33 %
• 50-59: 8.33 %
• 60+: 8.33 %

Common co-existing conditions for these people *:

1. Tremor (trembling or shaking movements in one or more parts of your body): 1 person, 6.67%
2. Hypotension (abnormally low blood pressure): 1 person, 6.67%
3. Fever: 1 person, 6.67%
4. Cytomegalovirus Test Positive: 1 person, 6.67%

Common drugs taken by these people *:

1. Methotrexate: 4 people, 26.67%
2. Blincyto: 4 people, 26.67%
3. Vincristine Sulfate: 3 people, 20.00%
4. Prednisone: 3 people, 20.00%
5. Methotrexate Sodium: 3 people, 20.00%
6. Zometa: 2 people, 13.33%
7. Sulfamethoxazole And Trimethoprim: 2 people, 13.33%
8. Micafungin: 2 people, 13.33%
9. Mercaptopurine: 2 people, 13.33%
10. Lasix: 2 people, 13.33%

Common symptoms for these people *:

1. Fever: 7 people, 46.67%
2. Hyperglycemia (high blood sugar): 5 people, 33.33%
3. Febrile Neutropenia (fever with reduced white blood cells): 5 people, 33.33%
4. Tumor Lysis Syndrome: 4 people, 26.67%
5. Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets): 3 people, 20.00%
6. Hypocalcaemia (levels of calcium in blood serum are abnormally low): 3 people, 20.00%
7. Fatigue (feeling of tiredness): 3 people, 20.00%
8. Hypokalemia (low potassium): 3 people, 20.00%
9. Diarrhea: 3 people, 20.00%
10. Cytokine Release Syndrome (immediate complication occurring with the use of anti-t cell antibody infusions): 3 people, 20.00%

Do you take medications and have Nosebleed?

- Check whether Nosebleed is associated with a drug or a condition